Psilera

Psilera Bioscience is a psychedelic-based biotechnology company developing its proprietary pipeline of neuromodulators to target central nervous system disorders. The company leverages research from pharmaceutical and cannabis industry executives to repurpose psychoactive natural products like DMT, creating therapies that improve mental health in the areas of mood, cognition, and substance use disorders. It formulates and screens lead compounds against neural targets to evaluate pipeline candidates for clinical potential in mood disorders, cognitive diseases, and addiction.